Biogen discontinues Alzheimer’s medication Aduhelm
By Carma Hassan and Jen Christensen, CNN (CNN) — The Alzheimer’s medication Aduhelm is being discontinued by drugmaker Biogen as it shifts resources to its other Alzheimer’s medication, Leqembi, and developing other treatments, the company said in a statement Wednesday. “As a pioneer in Alzheimer’s disease, Biogen is reprioritizing resources to build a leading franchise
Continue Reading